HSIC Henry Schein
FY2025 10-K
Filed: Feb 24, 2026
Consumer Discretionary
Wholesale-Medical, Dental & Hospital Equipment & SuppliesSEC EDGAR Henry Schein (HSIC) filed its fiscal year 2025 10-K annual report with the SEC on Feb 24, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.
AI Filing AnalysisFY2025 10-K
Business Overview
- • Global distribution of dental/medical products and services to office-based practitioners, supplemented by specialty products and healthcare technology software
- • Global Technology fastest-growing segment at +7.1% driven by cloud-based practice management platform adoption and revenue cycle management solutions; launched Global E-Commerce Platform (henryschein.com)
Management Discussion & Analysis
- • Revenue $13,184M in FY2025, up 4.0% YoY from $12,673M; internal growth 2.6%, acquisitions 0.9%, FX 0.5%
- • Gross margin 31.1% vs 31.7% prior year; operating expense ratio 26.2% vs 26.8%; effective tax rate 23.7% vs 24.9%
Risk Factors
- • CEO Stanley Bergman retiring March 1, 2026 after 37-year tenure; successor Frederick Lowery appointed January 2026 amid intensifying senior management competition
- • October 2023 cyberattack disrupted North American and European distribution operations; residual financial impact persisted through 2024 with ongoing remediation costs
Financial SummaryXBRL
Revenue
$13.2B
Net Income
$398M
Gross Margin
31.1%
Operating Margin
5.0%
Net Margin
3.0%
ROE
12.3%
Total Assets
$11.2B
EPS (Diluted)
$3.27
Operating Cash Flow
$712M
Source: XBRL data from Henry Schein FY2025 10-K filing on SEC EDGAR. All figures in USD.
Other Henry Schein Annual Reports
Get deeper insights on Henry Schein
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.